Eli Lilly Corp. buy The Goldman Sachs Group, Inc.
Start price
08.04.25
/
50%
€678.00
Target price
08.04.26
€810.30
Performance (%)
27.14%
Price
10.03.26
€862.00
Summary
This prediction is currently active. The prediction currently has a performance of 27.14%. This prediction currently runs until 08.04.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -0.712% | -0.712% |
| iShares Core DAX® | -3.520% | -4.987% |
| iShares Nasdaq 100 | 0.261% | 1.102% |
| iShares Nikkei 225® | -4.953% | -3.352% |
| iShares S&P 500 | -0.823% | -0.042% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $888.00 price target on the stock, down previously from $892.00.
Ratings data for LLY provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€881.10
13.12.25
13.12.25
€975.54
13.12.26
13.12.26
-2.17%
10.03.26
10.03.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€719.00
12.10.25
12.10.25
€756.64
12.10.26
12.10.26
19.89%
10.03.26
10.03.26